153 related articles for article (PubMed ID: 16831951)
1. Bone remodeling in health and disease: lessons from mathematical modeling.
Komarova SV
Ann N Y Acad Sci; 2006 Apr; 1068():557-9. PubMed ID: 16831951
[TBL] [Abstract][Full Text] [Related]
2. A theoretical model for simulating effect of parathyroid hormone on bone metabolism at cellular level.
Wang Y; Qin QH; Kalyanasundaram S
Mol Cell Biomech; 2009 Jun; 6(2):101-12. PubMed ID: 19496258
[TBL] [Abstract][Full Text] [Related]
3. Modeling the interactions between osteoblast and osteoclast activities in bone remodeling.
Lemaire V; Tobin FL; Greller LD; Cho CR; Suva LJ
J Theor Biol; 2004 Aug; 229(3):293-309. PubMed ID: 15234198
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid hormone: a double-edged sword for bone metabolism.
Qin L; Raggatt LJ; Partridge NC
Trends Endocrinol Metab; 2004 Mar; 15(2):60-5. PubMed ID: 15036251
[TBL] [Abstract][Full Text] [Related]
5. Studies on the mechanisms of the skeletal anabolic action of endogenous and exogenous parathyroid hormone.
Goltzman D
Arch Biochem Biophys; 2008 May; 473(2):218-24. PubMed ID: 18358824
[TBL] [Abstract][Full Text] [Related]
6. [Parathyroid and bone. Evidence and perspective of parathyroid therapy for patients with osteoporosis].
Wada S; Fukawa T; Kamiya S
Clin Calcium; 2007 Dec; 17(12):1888-94. PubMed ID: 18057665
[TBL] [Abstract][Full Text] [Related]
7. Back to the future: revisiting parathyroid hormone and calcitonin control of bone remodeling.
de Paula FJ; Rosen CJ
Horm Metab Res; 2010 May; 42(5):299-306. PubMed ID: 20217631
[TBL] [Abstract][Full Text] [Related]
8. [Regulation mechanisms of bone metabolism].
Fernandes MH
Acta Med Port; 1998 Jan; 11(1):41-52. PubMed ID: 9542178
[TBL] [Abstract][Full Text] [Related]
9. Skeletal actions of intermittent parathyroid hormone: effects on bone remodelling and structure.
Compston JE
Bone; 2007 Jun; 40(6):1447-52. PubMed ID: 17045858
[TBL] [Abstract][Full Text] [Related]
10. Mathematical Model of Bone Remodeling Captures the Antiresorptive and Anabolic Actions of Various Therapies.
Ross DS; Mehta K; Cabal A
Bull Math Biol; 2017 Jan; 79(1):117-142. PubMed ID: 27905067
[TBL] [Abstract][Full Text] [Related]
11. Anabolic therapies.
Marcus R
Clin Lab Med; 2000 Sep; 20(3):623-37, viii. PubMed ID: 10986625
[TBL] [Abstract][Full Text] [Related]
12. NFATc1: a novel anabolic therapeutic target for osteoporosis.
Yeo H; McDonald JM; Zayzafoon M
Ann N Y Acad Sci; 2006 Apr; 1068():564-7. PubMed ID: 16831953
[TBL] [Abstract][Full Text] [Related]
13. Influence of the parathyroid glands on bone metabolism.
Malluche HH; Koszewski N; Monier-Faugere MC; Williams JP; Mawad H
Eur J Clin Invest; 2006 Aug; 36 Suppl 2():23-33. PubMed ID: 16884395
[TBL] [Abstract][Full Text] [Related]
14. New mechanisms and targets in the treatment of bone fragility.
Martin TJ; Seeman E
Clin Sci (Lond); 2007 Jan; 112(2):77-91. PubMed ID: 17155930
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone stimulation of noncanonical Wnt signaling in bone.
Bergenstock MK; Partridge NC
Ann N Y Acad Sci; 2007 Nov; 1116():354-9. PubMed ID: 18083937
[TBL] [Abstract][Full Text] [Related]
16. [Hormones and osteoporosis update. Mechanisms of anabolic and catabolic effects of PTH on bone].
Kobayashi T
Clin Calcium; 2009 Jul; 19(7):911-8. PubMed ID: 19567985
[TBL] [Abstract][Full Text] [Related]
17. Intermittent Fugu parathyroid hormone 1 (1-34) is an anabolic bone agent in young male rats and osteopenic ovariectomized rats.
McManus JF; Davey RA; Maclean HE; Doust EA; Chiu WS; Sims NA; Bouxsein ML; Glatt V; Zajac JD; Danks JA
Bone; 2008 Jun; 42(6):1164-74. PubMed ID: 18387351
[TBL] [Abstract][Full Text] [Related]
18. A physiologically based mathematical model of integrated calcium homeostasis and bone remodeling.
Peterson MC; Riggs MM
Bone; 2010 Jan; 46(1):49-63. PubMed ID: 19732857
[TBL] [Abstract][Full Text] [Related]
19. [Assessment of bone quality. Bone remodeling and bone quality].
Sano G; Matsuo K
Clin Calcium; 2008 Mar; 18(3):315-20. PubMed ID: 18310818
[TBL] [Abstract][Full Text] [Related]
20. Calcium homeostasis: reassessment of the actions of parathyroid hormone.
Talmage RV; Mobley HT
Gen Comp Endocrinol; 2008 Mar; 156(1):1-8. PubMed ID: 18160068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
